Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Polycystins and Molecular Basis of Autosomal Dominant Polycystic Kidney Disease

In: Polycystic Kidney Disease [Internet]. Brisbane (AU): Codon Publications; 2015 Nov. Chapter 7.
Affiliations
Free Books & Documents
Review

Polycystins and Molecular Basis of Autosomal Dominant Polycystic Kidney Disease

Frederico Moraes Ferreira et al.
Free Books & Documents

Excerpt

Autosomal dominant polycystic kidney disease (ADPKD) is the most common renal monogenic disorder. It is characterized by progressive, bilateral renal cystic expansion followed by gradual loss of renal function after decades of life, while its systemic nature is reflected by extra-renal manifestations typically involving liver and the cardiovascular system. Cyst formation is triggered by mutations in the PKD1 or PKD2 genes. In most cysts, if not all, cystogenesis follows a two-hit model in developmental kidneys, while in the mature organ broad and fast cyst formation requires a third hit such as kidney injury. The first hit is represented by the germline mutation whereas a somatic total or partial inactivation of the previously normal allele constitutes the second event, a process that is consistent with the focal nature of ADPKD cystogenesis. PKD1 encodes polycystin-1 (PC1), a likely transmembrane mechano-sensor receptor comprised of a singular combination of structural domains present in other proteins. PKD2, in turn, encodes polycystin-2 (PC2), a non-selective cationic channel permeable to calcium composed by six transmembrane helices and intracytosolic C- and N-termini. In the primary cilium, PC1 regulates cell calcium influx by physically interacting with PC2 through their intracytosolic domains. Disruption of calcium cellular homeostasis increases cAMP cytosolic levels and affects cell cycle, leading to increased cell proliferation and transepithelial fluid secretion. In addition, disruption of PC1 C-terminus interactions with components of Wnt, mTOR, STAT3 and JAK2/STAT1 pathways is translated into a number of intracellular pathway abnormalities. In the same line, interactions between the PC2 C- and N-termini with ERK/B-Raf, GSK3β and other partners lead to disturbed cell proliferation, apoptosis and cell polarity. Mutations in PKD1 can result, moreover, in cell adhesion and extracellular matrix alterations, due to the role of PC1 extracellular domains in cell-cell and cell-matrix contact. Defects in the mentioned pathways can also impact oriented cell division, contributing to cyst growth.

PubMed Disclaimer

References

    1. Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med. 2009;60:321–37. doi: 10.1146/annurev.med.60.101707.125712. - DOI - PMC - PubMed
    1. Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med. 2008 Oct 2;359(14):1477–85. doi: 10.1056/NEJMcp0804458. - DOI - PubMed
    1. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millán JL, et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet. 1995 Jun;10(2):151–60. doi: 10.1038/ng0695-151. - DOI - PubMed
    1. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science. 1996 May 31;272(5266):1339–42. doi: 10.1126/science.272.5266.1339. - DOI - PubMed
    1. Hateboer N, Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet Lond Engl. 1999 Jan 9;353(9147):103–7. doi: 10.1016/S0140-6736(98)03495-3. - DOI - PubMed

LinkOut - more resources